Viridian Therapeutics, Inc. (0K1R.L)

USD 19.62

(-7.91%)

Eps Summary of Viridian Therapeutics, Inc.

  • Viridian Therapeutics, Inc.'s latest annual eps in 2023 was -5.31 USD , down -35.81% from previous year.
  • Viridian Therapeutics, Inc.'s latest quarterly eps in 2024 Q2 was -1.02 USD , down -29.11% from previous quarter.
  • Viridian Therapeutics, Inc. reported an annual eps of -3.91 USD in 2022, up 41.29% from previous year.
  • Viridian Therapeutics, Inc. reported an annual eps of -6.66 USD in 2021, up 78.65% from previous year.
  • Viridian Therapeutics, Inc. reported a quarterly eps of -1.02 USD for 2024 Q2, down -29.11% from previous quarter.
  • Viridian Therapeutics, Inc. reported a quarterly eps of -1.27 USD for 2023 Q2, up 21.12% from previous quarter.

Annual Eps Chart of Viridian Therapeutics, Inc. (2023 - 2012)

Historical Annual Eps of Viridian Therapeutics, Inc. (2023 - 2012)

Year Eps Eps Growth
2023 -5.31 USD -35.81%
2022 -3.91 USD 41.29%
2021 -6.66 USD 78.65%
2020 -31.20 USD -53.62%
2019 -20.31 USD -22.57%
2018 -16.57 USD 19.8%
2017 -20.66 USD -17.59%
2016 -17.57 USD 16.33%
2015 -21.00 USD 59.97%
2014 -52.46 USD -356.97%
2013 -11.48 USD 70.37%
2012 -38.75 USD 0.0%

Peer Eps Comparison of Viridian Therapeutics, Inc.

Name Eps Eps Difference
Xeris Biopharma Holdings, Inc. -0.45 USD -1080.0%
Arrowhead Pharmaceuticals, Inc. -1.91 USD -178.01%
Codexis, Inc. -1.12 USD -374.107%
Organovo Holdings, Inc. -1.60 USD -231.875%